Skip to main content
Mercator Medical logo

Mercator Medical — Investor Relations & Filings

Ticker · MRC ISIN · PLMRCTR00015 LEI · 259400YONW18M3H4WX66 WAR Manufacturing
Open in API
Filings indexed 1,123 across all filing types
Latest filing 2020-12-16 Capital/Financing Update
Country PL Poland
Listing WAR MRC

About Mercator Medical

https://en.mercatormedical.eu/

Mercator Medical is a manufacturer of medical gloves and a distributor of single-use medical materials. The company's core product portfolio includes a variety of disposable gloves, such as surgical, diagnostic, sterile, and protective types, alongside other disposable medical supplies. It operates on a dual model: as a manufacturer with a global distribution network selling to numerous countries worldwide, and as a distributor primarily focused on European markets. The business centers on providing single-use medical devices and personal protective equipment.

Recent filings

Filing Released Lang Actions
Piąte wezwanie akcjonariuszy Mercator Medical S.A. do złożenia dokumentów akcji - Content (PL)
Capital/Financing Update Classification · 92% confidence The document text is very short (658 characters) and appears to be a formal notice from Mercator Medical S.A. regarding the dematerialization of its shares, referencing a specific Polish law (art. 16 ustawy z dnia 30 sierpnia 2019 r.). It instructs shareholders on where and how to submit their share documents before a specific deadline (March 1, 2021). This type of mandatory corporate action announcement, which deals with capital structure changes (share dematerialization), fits best under 'Capital/Financing Update' (CAP) or potentially a general 'Regulatory Filing' (RNS). Since it directly concerns the formal structure and registration of shares, CAP is the most specific fit, as it relates to capital structure changes, even if it's a procedural notice rather than a fundraising event. Given the nature of the instruction and the short length, it is a specific announcement, not a comprehensive report.
2020-12-16 Polish
Zawarcie znaczącej umowy - Content (PL)
Regulatory Filings Classification · 95% confidence The document is a short announcement (728 characters) from the Management Board ('Zarząd spółki') of Mercator Medical S.A. It details the cumulative value of agreements made over the last 12 months with a related party (SUPERMAX Corporation Berhad) and states that this value exceeds 10% of the consolidated sales revenue for the last four reporting quarters. This type of disclosure, concerning significant transactions with related parties that cross a materiality threshold (10% of revenue), is typically a mandatory regulatory disclosure in many jurisdictions, often falling under general regulatory announcements or specific transaction disclosure rules. Given the options, it is not a full financial report (10-K, IR), an earnings release (ER), or a management discussion (MDA). It is a specific, material transaction disclosure. Since there is no specific code for 'Related Party Transaction Disclosure,' and it is a formal regulatory announcement, the most appropriate fallback category is 'Regulatory Filings' (RNS), as it is a mandatory disclosure of a significant event/transaction.
2020-12-16 Polish
Zawiadomienie o zmianie stanu posiadania
Major Shareholding Notification Classification · 98% confidence The document is a formal notification dated December 15, 2020, addressed to the Polish Financial Supervision Authority (Komisja Nadzoru Finansowego) and Mercator Medical SA. The content explicitly references Article 69 of the Polish Act on Public Offering, detailing a change in the total number of votes held by Anabaza Limited due to the disposal (zbycie) of 500,000 shares. This structure—reporting a change in shareholding percentage crossing a threshold (from 71.26% down to 67.86% direct voting rights, and 72.59% down to 69.19% total voting rights)—is characteristic of a Major Shareholding Notification, which in the provided schema maps to 'MRQ' (Major Shareholding Notification). Although the text is in Polish, the regulatory context points directly to this type of filing.
2020-12-16 Polish
Znaczne pakiety akcji - Content (PL)
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document text is very short (286 characters) and states that the Management Board received a notification regarding a change in the shareholding percentage ('zmianie udziału w ogólnej liczbie głosów Emitenta') and that the content of the notification is attached ('Treść powiadomienia Emitent przekazuje w załączeniu'). This structure—a brief announcement stating that detailed information is attached—strongly suggests a Report Publication Announcement (RPA) or a general Regulatory Filing (RNS), based on the 'MENU VS MEAL' rule. Since the content specifically relates to a change in shareholding percentage, the most precise category is Major Shareholding Notification (MRQ). However, because the text itself is only the announcement wrapper and not the detailed notification content, RPA is a strong candidate if the attached document is the primary filing. Given the specific nature of the content (change in voting rights/shareholding), MRQ is the subject matter, but the format is an announcement wrapper. In many regulatory contexts, a brief announcement of a major shareholder change is classified by the subject matter (MRQ). Since the text explicitly mentions a notification about a change in the total number of votes/shareholding, MRQ (Major Shareholding Notification) is the most accurate subject classification, even if the format is an announcement wrapper. If the wrapper itself is the only document, RPA or RNS would apply, but MRQ describes the core event being reported.
2020-12-16 Polish
Powiadomienie o zmianie udziału
Major Shareholding Notification Classification · 98% confidence The document is a formal notification written in Polish, addressed to the Polish Financial Supervision Authority (Komisja Nadzoru Finansowego). It explicitly references Article 69 of the Polish Act on Public Offering and conditions for introducing financial instruments to organized trading, which governs notifications regarding changes in the total number of votes held by a shareholder or a group of related parties. The content details the change in the percentage of votes held by Wiesław Żyznowski due to the sale of shares by an affiliated entity (Anabaza Limited) and his wife. This type of mandatory disclosure concerning changes in significant shareholdings or voting rights thresholds is classified as a Major Shareholding Notification.
2020-12-16 Polish
Znaczne pakiety akcji - Content (PL)
Major Shareholding Notification Classification · 99% confidence The document text is very short (269 characters) and originates from the Management Board ('Zarząd') of Mercator Medical S.A. It explicitly states that the company received a notification ('powiadomienie') on December 15, 2020, regarding a change in the shareholding/voting rights ('zmianie udziału w ogólnej liczbie głosów') held by Mr. Wiesław Żyznowski. This content directly relates to changes in significant share ownership thresholds, which corresponds to the Major Shareholding Notification category (MRQ). Although it mentions the content is attached, the core subject matter is the notification itself, making MRQ more specific than the general RPA or RNS.
2020-12-16 Polish

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.